Gail K. Naughton

Director, BARD C R INC /NJ/.

Companies

TherapeuticsMD, Inc.Board member Mar 26, 2020 to now¹
Cel-Sci (United States)Board member Aug 8, 2022 to Aug 10, 2023²
Histogen Inc.Officer May 28, 2020 to Jan 15, 2021³
Plus TherapeuticsBoard member Jul 2, 2014 to Nov 29, 2017⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

TherapeuticsMD, Inc. TXMD8,500 shares⁵$16.1K at $1.90Feb 18, 2025
Cel-Sci (United States) CVM0 shares⁶Aug 8, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Feb 18, 2025Exercised options 8,500 shares of TherapeuticsMD, Inc.⁵
Dec 7, 2022Sold 3,922 shares at $5.26 of TherapeuticsMD, Inc.⁷
Aug 18, 2022Exercised options 1,984 shares of TherapeuticsMD, Inc.⁸

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARTherapeuticsMD, Inc., Board member
2
SEC EDGARCel-Sci (United States), Board member
3
SEC EDGARHistogen Inc., Officer
4
SEC EDGARPlus Therapeutics, Board member
5
SEC EDGARTherapeuticsMD, Inc. shares after the filing of Feb 18, 2025
6
SEC EDGARCel-Sci (United States) shares after the filing of Aug 8, 2022
7
SEC EDGARForm 4 filed Dec 8, 2022
8
SEC EDGARForm 4 filed Aug 22, 2022